Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies

Extreme prematurity is the leading cause of death among children under 5 years of age. Currently, there is no treatment for bronchopulmonary dysplasia (BPD), the most common complication of extreme prematurity. Experimental studies in animal models of BPD suggest that mesenchymal stromal cells (MSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustine, Sajit, Avey, Marc T., Harrison, Brittany, Locke, Tiffany, Ghannad, Mona, Moher, David, Thébaud, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702524/
https://www.ncbi.nlm.nih.gov/pubmed/29045045
http://dx.doi.org/10.1002/sctm.17-0126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702524/
https://www.ncbi.nlm.nih.gov/pubmed/29045045
http://dx.doi.org/10.1002/sctm.17-0126

Ejemplares similares